Cargando…

Effects of pre-emptive pregabalin and multimodal anesthesia on postoperative opioid requirements in patients undergoing robot-assisted laparoscopic prostatectomy

BACKGROUND: Previous findings indicate that pre-emptive pregabalin as part of multimodal anesthesia reduces opioid requirements compared to conventional anesthesia in patients undergoing robot-assisted laparoscopic prostatectomy (RALP). However, recent studies show contradictory evidence suggesting...

Descripción completa

Detalles Bibliográficos
Autores principales: Sisa, K., Huoponen, S., Ettala, O., Antila, H., Saari, T. I., Uusalo, P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7856812/
https://www.ncbi.nlm.nih.gov/pubmed/33530959
http://dx.doi.org/10.1186/s12894-021-00785-9
_version_ 1783646319455240192
author Sisa, K.
Huoponen, S.
Ettala, O.
Antila, H.
Saari, T. I.
Uusalo, P.
author_facet Sisa, K.
Huoponen, S.
Ettala, O.
Antila, H.
Saari, T. I.
Uusalo, P.
author_sort Sisa, K.
collection PubMed
description BACKGROUND: Previous findings indicate that pre-emptive pregabalin as part of multimodal anesthesia reduces opioid requirements compared to conventional anesthesia in patients undergoing robot-assisted laparoscopic prostatectomy (RALP). However, recent studies show contradictory evidence suggesting that pregabalin does not reduce postoperative pain or opioid consumption after surgeries. We conducted a register-based analysis on RALP patients treated over a 5-year period to evaluate postoperative opioid consumption between two multimodal anesthesia protocols. METHODS: We retrospectively evaluated patients undergoing RALP between years 2015 and 2019. Patients with American Society of Anesthesiologists status 1–3, age between 30 and 80 years and treated with standard multimodal anesthesia were included in the study. Pregabalin (PG) group received 150 mg of oral pregabalin as premedication before anesthesia induction, while the control (CTRL) group was treated conventionally. Postoperative opioid requirements were calculated as intravenous morphine equivalent doses for both groups. The impact of pregabalin on postoperative nausea and vomiting (PONV), and length of stay (LOS) was evaluated. RESULTS: We included 245 patients in the PG group and 103 in the CTRL group. Median (IQR) opioid consumption over 24 postoperative hours was 15 (8–24) and 17 (8–25) mg in PG and CTRL groups (p = 0.44). We found no difference in postoperative opioid requirement between the two groups in post anesthesia care unit, or within 12 h postoperatively (p = 0.16; p = 0.09). The length of post anesthesia care unit stay was same in each group and there was no difference in PONV Similarly, median postoperative LOS was 31 h in both groups. CONCLUSION: Patients undergoing RALP and receiving multimodal analgesia do not need significant amount of opioids postoperatively and can be discharged soon after the procedure. Pre-emptive administration of oral pregabalin does not reduce postoperative opioid consumption, PONV or LOS in these patients.
format Online
Article
Text
id pubmed-7856812
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-78568122021-02-04 Effects of pre-emptive pregabalin and multimodal anesthesia on postoperative opioid requirements in patients undergoing robot-assisted laparoscopic prostatectomy Sisa, K. Huoponen, S. Ettala, O. Antila, H. Saari, T. I. Uusalo, P. BMC Urol Research Article BACKGROUND: Previous findings indicate that pre-emptive pregabalin as part of multimodal anesthesia reduces opioid requirements compared to conventional anesthesia in patients undergoing robot-assisted laparoscopic prostatectomy (RALP). However, recent studies show contradictory evidence suggesting that pregabalin does not reduce postoperative pain or opioid consumption after surgeries. We conducted a register-based analysis on RALP patients treated over a 5-year period to evaluate postoperative opioid consumption between two multimodal anesthesia protocols. METHODS: We retrospectively evaluated patients undergoing RALP between years 2015 and 2019. Patients with American Society of Anesthesiologists status 1–3, age between 30 and 80 years and treated with standard multimodal anesthesia were included in the study. Pregabalin (PG) group received 150 mg of oral pregabalin as premedication before anesthesia induction, while the control (CTRL) group was treated conventionally. Postoperative opioid requirements were calculated as intravenous morphine equivalent doses for both groups. The impact of pregabalin on postoperative nausea and vomiting (PONV), and length of stay (LOS) was evaluated. RESULTS: We included 245 patients in the PG group and 103 in the CTRL group. Median (IQR) opioid consumption over 24 postoperative hours was 15 (8–24) and 17 (8–25) mg in PG and CTRL groups (p = 0.44). We found no difference in postoperative opioid requirement between the two groups in post anesthesia care unit, or within 12 h postoperatively (p = 0.16; p = 0.09). The length of post anesthesia care unit stay was same in each group and there was no difference in PONV Similarly, median postoperative LOS was 31 h in both groups. CONCLUSION: Patients undergoing RALP and receiving multimodal analgesia do not need significant amount of opioids postoperatively and can be discharged soon after the procedure. Pre-emptive administration of oral pregabalin does not reduce postoperative opioid consumption, PONV or LOS in these patients. BioMed Central 2021-02-02 /pmc/articles/PMC7856812/ /pubmed/33530959 http://dx.doi.org/10.1186/s12894-021-00785-9 Text en © The Author(s) 2021 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research Article
Sisa, K.
Huoponen, S.
Ettala, O.
Antila, H.
Saari, T. I.
Uusalo, P.
Effects of pre-emptive pregabalin and multimodal anesthesia on postoperative opioid requirements in patients undergoing robot-assisted laparoscopic prostatectomy
title Effects of pre-emptive pregabalin and multimodal anesthesia on postoperative opioid requirements in patients undergoing robot-assisted laparoscopic prostatectomy
title_full Effects of pre-emptive pregabalin and multimodal anesthesia on postoperative opioid requirements in patients undergoing robot-assisted laparoscopic prostatectomy
title_fullStr Effects of pre-emptive pregabalin and multimodal anesthesia on postoperative opioid requirements in patients undergoing robot-assisted laparoscopic prostatectomy
title_full_unstemmed Effects of pre-emptive pregabalin and multimodal anesthesia on postoperative opioid requirements in patients undergoing robot-assisted laparoscopic prostatectomy
title_short Effects of pre-emptive pregabalin and multimodal anesthesia on postoperative opioid requirements in patients undergoing robot-assisted laparoscopic prostatectomy
title_sort effects of pre-emptive pregabalin and multimodal anesthesia on postoperative opioid requirements in patients undergoing robot-assisted laparoscopic prostatectomy
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7856812/
https://www.ncbi.nlm.nih.gov/pubmed/33530959
http://dx.doi.org/10.1186/s12894-021-00785-9
work_keys_str_mv AT sisak effectsofpreemptivepregabalinandmultimodalanesthesiaonpostoperativeopioidrequirementsinpatientsundergoingrobotassistedlaparoscopicprostatectomy
AT huoponens effectsofpreemptivepregabalinandmultimodalanesthesiaonpostoperativeopioidrequirementsinpatientsundergoingrobotassistedlaparoscopicprostatectomy
AT ettalao effectsofpreemptivepregabalinandmultimodalanesthesiaonpostoperativeopioidrequirementsinpatientsundergoingrobotassistedlaparoscopicprostatectomy
AT antilah effectsofpreemptivepregabalinandmultimodalanesthesiaonpostoperativeopioidrequirementsinpatientsundergoingrobotassistedlaparoscopicprostatectomy
AT saariti effectsofpreemptivepregabalinandmultimodalanesthesiaonpostoperativeopioidrequirementsinpatientsundergoingrobotassistedlaparoscopicprostatectomy
AT uusalop effectsofpreemptivepregabalinandmultimodalanesthesiaonpostoperativeopioidrequirementsinpatientsundergoingrobotassistedlaparoscopicprostatectomy